MedPath

Prevention of diabetes with a novel butyrate-enriched triglyceride

Conditions
Obesitas
Insulin resistance
prediabetes
10018424
Registration Number
NL-OMON56880
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
48
Inclusion Criteria

Male/female
Age 20-70 year
BMI 28-40 kg/m2 (weight in kg / length in m)
One of the following criteria: fasting glucose 5.6-6.9 mmol/l OR postprandial
glucose (2h) 7.8-11.1 mmol/l OR HOMA-IR>2.2

Exclusion Criteria

Cardiovascular, pulmonary, metabolic (including diabetes mellitus),
gastro-intestinal, liver, kidney or auto-immune disease
Malignancy or disease with life expectancy <5 years
Substance abuse (drugs, alcohol)
Weight change >3kg in past 3 months
Pre/pro/antibiotic use past 3 months or during trial
Use of medication interfering with study outcomes
Streneous physical activity (>3h per week)
Diet-restrictions (hypocaloric, vegan, vegetarian)
Pregnancy
Use of laxatives
Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath